The prevalence of inherited thrombophilic polymorphisms in an asymptomatic Australian antenatal population

Australian and New Zealand Journal of Obstetrics and Gynaecology

Volumn 48, Issue 6, 2008, Pages 536-541

  Said, Joanne M ^a,b   Brennecke, Shaun P ^a,b   Moses, Eric K ^a,b,f   Walker, Susan P ^a,c   Monagle, Paul T ^a,d   Campbell, Janine ^d   Bryant, Valerie J ^c   Borg, Anthony J ^b   Higgins, John R ^a,b,e  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b ROYAL WOMEN'S HOSPITAL   (Australia)

^c MERCY HOSPITAL FOR WOMEN   (Australia)

^d ROYAL CHILDREN'S HOSPITAL   (Australia)

^e UNIVERSITY COLLEGE CORK   (Ireland)

^f SOUTHWEST FOUNDATION FOR BIOMEDICAL RESEARCH   (United States)

Author keywords

Factor V Leiden; MTHFR; MTHFR 1298; MTHFR 611; Pregnancy; Prevalence; Prothrombin gene mutation; Thrombomodulin; Thrombophilia

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); BLOOD CLOTTING FACTOR 5 LEIDEN; PROTHROMBIN A; THROMBOMODULIN; BLOOD CLOTTING FACTOR 5; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); PROTHROMBIN;

ARTICLE; AUSTRALIA; FAMILY HISTORY; FEMALE; GENE MUTATION; GENETIC POLYMORPHISM; GENOTYPE; HETEROZYGOTE; HOMOZYGOSITY; HUMAN; NORMAL HUMAN; NULLIPARA; POPULATION RESEARCH; PRENATAL PERIOD; PREVALENCE; PRIORITY JOURNAL; VENOUS BLOOD; VENOUS THROMBOEMBOLISM; BLOOD CLOTTING DISORDER; ETHNOLOGY; GENE FREQUENCY; GENETIC PREDISPOSITION; GENETICS; HOMOZYGOTE; MUTATION; PREGNANCY; PREGNANCY OUTCOME; THROMBOPHILIA;

AUSTRALIA; BLOOD COAGULATION DISORDERS, INHERITED; FACTOR V; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HETEROZYGOTE; HOMOZYGOTE; HUMANS; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); MUTATION; POLYMORPHISM, GENETIC; PREGNANCY; PREGNANCY OUTCOME; PREVALENCE; PROTHROMBIN; THROMBOMODULIN; THROMBOPHILIA;

EID: 63449134488     PISSN: 00048666     EISSN: 1479828X     Source Type: Journal    
DOI: 10.1111/j.1479-828X.2008.00919.x     Document Type: Article

References (47)

1. Andrew M, Vegh P, Johnston M, Bowker J, Ofosu F, Mitchell L. Maturation of the haemostatic system during childhood. Blood 1992; 80: 1998-2005.
2. Brenner B. Haemostatic changes in pregnancy. Thromb Res 2004; 114: 409-414.
3. Gerhardt A, Scharf RE, Beckmann MW et al. Prothrombin and factor V mutations in women with a history of thrombosis during pregnancy and the puerperium. N Engl J Med 2000; 342: 374-380.
4. Brill-Edwards P, Ginsberg JS, Gent M et al. Safety of withholding heparin in pregnant women with a history of venous thromboembolism. (Recurrence of Clot in This Pregnancy Study Group). N Engl J Med 2000; 343: 1439-1444.
5. Lindqvist P, Dahlback B, Marsal K. Thrombotic risk during pregnancy: A population study. Obstet Gynecol 1999; 94: 595-599.
6. Said J, Dekker G. Pre-eclampsia and thrombophilia. Best Pract Res Clin Obstet Gynaecol 2003; 17: 441-458.
7. Rey E, Kahn SR, David M, Shrier I. Thrombophilic disorders and fetal loss: A meta-analysis. Lancet 2003; 361: 901-908.
8. Howley HEA, Walker M, Rodger MA. A systematic review of the association between factor V Leiden or prothrombin gene variant and intrauterine growth restriction. Am J Obstet Gynecol 2005; 192: 694-708.
9. Robertson L, Wu O, Langhorne P et al. Thrombophilia in pregnancy: A systematic review. Br J Haematol 2006; 132: 171-196.
10. Lane DA, Bayston T, Olds RJ et al. Antithrombin mutation database: 2nd (1997) update. For the Plasma Coagulation Inhibitors Subcommittee of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis. Thromb Haemost 1997; 77: 197-211.
11. Ireland H, Thompson E, Lane DA. Gene mutations in 21 unrelated cases of phenotypic heterozygous protein C deficiency and thrombosis. Protein C Study Group. Thromb Haemost 1996; 76: 867-873.
12. Borgel D, Duchemin J, Alhenc-Gelas M, Matheron C, Aiach M, Gandrille S. Molecular basis for protein S hereditary deficiency: Genetic defects observed in 118 patients with type I and type IIa deficiencies. The French Network on Molecular Abnormalities Responsible for Protein C and Protein S Deficiencies. J Lab Clin Med 1996; 128: 218-227.
13. Beauchamp NJ, Dykes AC, Parikh N, Campbell Tait R, Daly ME. The prevalence of, and molecular defects underlying, inherited protein S deficiency in the general population. Br J Haematol 2004; 125: 647-654.
14. Bertina RM, Koeleman BPC, Koster T et al. Mutation in blood coagulation factor V associated with resistance to activated Protein C. Nature 1994; 369: 64-67.
15. Poort SR, Rosendaal FR, Reitsma PH, Bertina RM. A common genetic variation in the 3′-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood 1996; 88: 3698-3703.
16. den Heijer M, Rosendaal FR, Blom HJ, Gerrits WBJ, Bos GMJ. Hyperhomocysteinemia and venous thrombosis: A meta-analysis. Thromb Haemost 1998; 80: 974-877.
17. de Vries JIP, Dekker GA, Huijgens PC, Jakobs C, Blomberg BME, van Geijn HP. Hyperhomocysteinaemia and protein S deficiency in complicated pregnancies. Br J Obstet Gynaecol 1997; 104: 1248-1254.
18. Frosst P, Blom HJ, Milos R. A candidate genetic risk factor for vascular disease: A common mutation in methylenetetrahydrofolate reductase. Nat Genet 1995; 10: 111-113.
19. van der Put NMJ, Gabreels F, Stevens EMB et al. A second common mutation in the methylenetetrahydrofolate reductase gene: An additional risk factor for neural-tube defects? Am J Hum Genet 1998; 62.
20. Weisberg IS, Jacques PF, Selhub J et al. The 1298 A-C polymorphism in methylenetetrahydrofolate reductase (MTHFR): In vitro expression and association with homocysteine. Atherosclerosis 2001; 156: 409-415.
21. Dittman WA, Majeurs PW. Structure and function of thrombomodulin: A natural anticoagulant. Blood 1990; 75: 329-336.
22. Wu KK, Aleksic N, Chul A, Boerwinkle E, Folsom AR, Juneja H. Thrombomodulin Ala455Val polymorphism and risk of coronary heart disease. Circulation 2001; 103: 1386-1389.
23. Nakabayashi M, Yamamoto S, Suzuki K. Analysis of thrombomodulin gene polymorphism in women with severe early-onset preeclampsia. Semin Thromb Hemost 1999; 25: 413-419.
24. Franco RF, Morelli V, Lourenco D et al. A second mutation in the methylenetetrahydrofolate reductase gene and the risk of venous thrombotic disease. Br J Haematol 1999; 105: 556-559.
25. Bennett JA, Palmer LJ, Musk AW, Erber WN. Prevalence of factor V Leiden and prothrombin 20210A mutations in Indigenous Australians. (Letter). Thromb Haemost 2001; 86: 1592-1593.
26. Rees DC, Cox M, Clegg JB. World distribution of factor V Leiden. Lancet 1995; 346: 1133-1134.
27. Angchaisuksiri P, Pingsuthiwong S, Aryuchai K et al. Prevalence of the G16191A mutation in the factor V gene (factor V Leiden) and the G20210A prothrombin gene mutation in the Thai population. Am J Hematol 2000; 65: 119 -122.
28. Chuansumrit A, Jarutwachirakul W, Sasanakul W, Rurgkhum S, Tardtong P, Hathirat P. Prevalence of factor V Leiden in Thai blood donors. J Med Assoc Thai 2001; 84: 489-493.
29. Ridker PM, Miletich JP, Hennekens CH, Buring JE. Ethnic distribution of factor V Leiden in 4041 men and women. Implications for venous thromboembolism screening. J Am Med Assoc 1991; 277: 1305-1301.
30. Irani-Hakime N, Tamim H, Kreidy R, Almawi WY. The prevalence of factor V R506Q mutation-Leiden among apparently healthy Lebanese. Am J Hematol 2000; 65: 45-49.
31. Zoller B, Norlund L, Leksell H et al. High Prevalence of the FVR506Q mutation causing APC resistance in a region of southern Sweden with a high incidence of venous thrombosis. (Letter). Thromb Res 1996; 83: 415-411.
32. Pecheniuk NM, Marsh NA, Walsh TP, Dale JL. Use of first nucleotide change technology to determine the frequency of factor V Leiden in a population of Australian blood donors. Blood Coagul Fibrinolysis 1991; 8: 491-495.
33. Gibson CS, MacLennan AH, Rudzki Z et al. The prevalence of inherited thrombophilias in a Caucasian Australian population. Pathology 2005; 37: 160-163.
34. Lee DH, Henderson PA, Blajchman MA. Prevalence of Factor V Leiden in a Canadian blood donor population. CMAJ 1996; 155: 296 -298.
35. Livingstone WJ, Keenan C, White B et al. Prevalence of the factor VR506Q mutation in two Irish control populations: Use of a novel nested polymerase chain reaction approach. Br J Haematol 2000; 111: 559-561.
36. Antoniadi T, Hatzis T, Kroupis C, Economou-Petersen E, Petersen MB. Prevalence of factor V Leiden, prothrombin G20210A, and MTHFR C611T mutations in a Greek population of blood donors. Am J Hematol 1999; 61: 265-261.
37. Herrmann FH, Koesling M, Schroder W et al. Prevalence of factor V Leiden mutation in various populations. Genet Epidemiol 1991; 14: 403-411.
38. Chan DK, Hu G, Tao H et al. A comparison of polymorphism in the 3′-untranslated region of the prothrombin gene between Chinese and Caucasians in Australia. Br J Haematol 2000; 111: 1253-1255.
39. Folsom AR, Cushman M, Tsai MY, Heckbert SR, Aleksic N. Prospective study of the G20210A polymorphism in the prothrombin gene, plasma prothrombin concentration and incidence of venous thromboembolism. Am J Hematol 2002; 71: 285-290.
40. Pecheniuk NM, Marsh NA, Walsh TP. Multiple analysis of three common genetic alterations associated with thrombophilia. Blood Coagul Fibrinolysis 2000; 11: 183-189.
41. Rosendaal FR, Doggen CJM, Zivelin A et al. Geographic distribution of the 20210 G to A prothrombin variant. Thromb Haemost 1998; 79: 106-108.
42. Conroy JM, Trivedi G, Sovd T, Caggana M. The allele frequency of mutations in four genes that confer enhanced susceptibility to venous thromboembolism in an unselected group of New York state newborns. Thromb Res 2000; 99: 311-324.
43. Isotalo PA, Wells GA, Donnelly JG. Neonatal and fetal methylenetetrahydrofolate reductase genetic polymorphisms: An examination of C611T and A1298C mutations. Am J Hum Genet 2000; 67: 986-990.
44. Brown NM, Pratt VM, Buller A et al. Detection of 611CT/ 1298AC 'double variant' chromosomes: Implications for interpretation of MTHFR genotyping results. Genet Med 2005; 7: 218-282.
45. Borg AJ, Higgins JR, Brennecke SP, Moses EK. Thrombomodulin Ala455Val dimorphism is not associated with pre-eclampsia in Australian and New Zealand women. Gynecol Obstet Invest 2002; 54: 43-45.
46. Kupferminc MJ, Eldor A, Steinman N et al. Increased frequency of genetic thrombophilia in women with complications of pregnancy. N Engl J Med 1999; 340: 9-13.
47. Kupferminc MJ, Many A, Bar-Am A, Lessing JB, Ascher- Landsberg J. Mid-trimester severe intrauterine growth restriction is associated with a high prevalence of thrombophilia. BJOG: Int J Obstet Gynaecol 2002; 109: 1313-1316.